Xin Chen
75Patents
11h-index
173Co-inventors
81Inventor score
Filing activity: May 28, 1998 → May 18, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7361678B2 | Azole derivatives and fused bicyclic azole derivatives as therapeutic agents | Chemistry; Metallurgy | 76 | Expired |
| US7700594B2 | Fused bicyclic mTOR inhibitors | Chemistry; Metallurgy | 34 | Active |
| US7638541B2 | 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine | Chemistry; Metallurgy | 33 | Active |
| US7449478B2 | Indole compounds | Chemistry; Metallurgy | 23 | Expired |
| US10730870B2 | Compounds and methods for the enhanced degradation of targeted proteins | Chemistry; Metallurgy | 20 | Active |
| US8399433B2 | Amino pyrimidine anticancer compounds | Chemistry; Metallurgy | 17 | Active |
| US11085076B2 | Synthesis of novel disulfide linker based nucleotides as reversible terminators for DNA sequencing by synthesis | Chemistry; Metallurgy | 14 | Active |
| US7923555B2 | Fused bicyclic mTor inhibitors | Chemistry; Metallurgy | 13 | Active |
| US8314111B2 | Fused bicyclic motor inhibitors | Chemistry; Metallurgy | 12 | Active |
| US8476308B2 | GPR120 receptor agonists and uses thereof | Chemistry; Metallurgy | 12 | Active |
| US11999999B2 | Synthesis of novel disulfide linker based nucleotides as reversible terminators for DNA sequencing by synthesis | Chemistry; Metallurgy | 12 | Active |
| US8183381B2 | N-linked heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders | Chemistry; Metallurgy | 11 | Active |
| US6365711B1 | Methods and reagents for modulating TGF-&bgr; superfamily signalling | Physics | 11 | Expired |
| US7737285B2 | Azole derivatives and fused bicyclic azole derivatives as therapeutic agents | Chemistry; Metallurgy | 11 | Active |
| US7714013B2 | Azole derivatives and fused bicyclic azole derivatives as therapeutic agents | Chemistry; Metallurgy | 11 | Active |
| US8227495B2 | 2,4-disubsituted thiazoles and pharmaceutical compositions thereof | Chemistry; Metallurgy | 10 | Active |
| US7943767B2 | Fused bicyclic mTOR inhibitors | Chemistry; Metallurgy | 7 | Active |
| US8288384B2 | Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders | Chemistry; Metallurgy | 7 | Active |
| US8487073B2 | Melanocortin receptor-specific peptides for treatment of sexual dysfunction | Human Necessities | 7 | Active |
| US9096624B2 | Amino pyrimidine anticancer compounds | Chemistry; Metallurgy | 6 | Active |
| US7432394B2 | Resolution of α-(phenoxy) phenylacetic acid derivatives with naphthyl-alkylamines | Chemistry; Metallurgy | 6 | Active |
| US7714131B2 | Process for the stereoselective preparation of (−)-halofenate and derivatives thereof | Chemistry; Metallurgy | 6 | Active |
| US8796455B2 | Fused bicyclic mTOR inhibitors | Chemistry; Metallurgy | 6 | Active |
| US8598374B2 | GPR120 receptor agonists and uses thereof | Chemistry; Metallurgy | 5 | Active |
| US7687504B2 | Pyrrolidine compounds | Chemistry; Metallurgy | 5 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.